1. Home
  2. STOK vs ESTA Comparison

STOK vs ESTA Comparison

Compare STOK & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • ESTA
  • Stock Information
  • Founded
  • STOK 2014
  • ESTA 2004
  • Country
  • STOK United States
  • ESTA Costa Rica
  • Employees
  • STOK N/A
  • ESTA N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • ESTA Industrial Specialties
  • Sector
  • STOK Health Care
  • ESTA Health Care
  • Exchange
  • STOK Nasdaq
  • ESTA Nasdaq
  • Market Cap
  • STOK 1.3B
  • ESTA 1.4B
  • IPO Year
  • STOK 2019
  • ESTA 2018
  • Fundamental
  • Price
  • STOK $23.19
  • ESTA $65.07
  • Analyst Decision
  • STOK Strong Buy
  • ESTA Strong Buy
  • Analyst Count
  • STOK 9
  • ESTA 7
  • Target Price
  • STOK $31.00
  • ESTA $66.71
  • AVG Volume (30 Days)
  • STOK 1.4M
  • ESTA 611.9K
  • Earning Date
  • STOK 11-04-2025
  • ESTA 11-05-2025
  • Dividend Yield
  • STOK N/A
  • ESTA N/A
  • EPS Growth
  • STOK N/A
  • ESTA N/A
  • EPS
  • STOK 0.68
  • ESTA N/A
  • Revenue
  • STOK $205,632,000.00
  • ESTA $190,973,000.00
  • Revenue This Year
  • STOK $416.54
  • ESTA $28.32
  • Revenue Next Year
  • STOK N/A
  • ESTA $23.92
  • P/E Ratio
  • STOK $33.39
  • ESTA N/A
  • Revenue Growth
  • STOK 1128.17
  • ESTA 24.76
  • 52 Week Low
  • STOK $5.35
  • ESTA $26.56
  • 52 Week High
  • STOK $38.69
  • ESTA $65.45
  • Technical
  • Relative Strength Index (RSI)
  • STOK 33.50
  • ESTA 80.37
  • Support Level
  • STOK $20.32
  • ESTA $47.00
  • Resistance Level
  • STOK $33.88
  • ESTA $54.01
  • Average True Range (ATR)
  • STOK 2.07
  • ESTA 3.32
  • MACD
  • STOK -1.56
  • ESTA 1.43
  • Stochastic Oscillator
  • STOK 18.78
  • ESTA 97.91

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About ESTA Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Share on Social Networks: